Cargando…
Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies
OBJECTIVE—Observational studies assessing the association of combination therapy of metformin and sulfonylurea on all-cause and/or cardiovascular mortality in type 2 diabetes have shown conflicting results. We therefore evaluated the effects of combination therapy of sulfonylureas and metformin on t...
Autores principales: | Rao, Ajay D., Kuhadiya, Nitesh, Reynolds, Kristi, Fonseca, Vivian A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494623/ https://www.ncbi.nlm.nih.gov/pubmed/18458139 http://dx.doi.org/10.2337/dc08-0167 |
Ejemplares similares
-
Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes: Meta-analysis of observational studies
por: Kramer, Caroline K., et al.
Publicado: (2011) -
Hypoglycemia, Diabetes, and Cardiovascular Events
por: Desouza, Cyrus V., et al.
Publicado: (2010) -
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
por: Lipska, Kasia J., et al.
Publicado: (2011) -
Metformin for Obesity in Children and Adolescents: A Systematic Review
por: Park, Min Hae, et al.
Publicado: (2009) -
Beyond the Monofilament for the Insensate Diabetic Foot: A systematic review of randomized trials to prevent the occurrence of plantar foot ulcers in patients with diabetes
por: Arad, Yadon, et al.
Publicado: (2011)